The company has to compulsorily wind up the company if it cannot relist within 3 years of suspension. So if this doesn't get up, there is no more chances and we lose almost all our invested funds.
RBL Recce Pharmaceuticals advances global reach with Indonesia’s approval for Phase 3 Diabetic Foot Infection Trial